0
Russia has granted regulatory approval to a second Covid-19 vaccine, according to its register of authorised medicines. A delighted President Vladimir Putin announced the news at a government meeting.
The jab was developed by the Vector Institute in Siberia and completed early-stage human trials last month. However, results have not been published yet and a large-scale trial, known as Phase III, has not yet begun.
